StockWatch
·
Pharmaceuticals
Clarification21 Aug 2026, 04:05 pm

Gujarat Terce Labs Corrects MD & CEO Re-appointment Tenure

AI Summary

Gujarat Terce Laboratories Ltd has issued a corrigendum to its earlier intimation regarding the re-appointment of Mr. Aalap Prajapati as Managing Director & Chief Executive Officer. The company clarified that the re-appointment tenure is for three years, from October 28, 2026, to October 27, 2029, correcting an inadvertent error in the previously stated five-year tenure. The shareholders approved the three-year term at the 41st Annual General Meeting held on August 21, 2026. All other details from the original intimation remain unchanged.

Key Highlights

  • Gujarat Terce Labs corrects MD & CEO re-appointment tenure.
  • Re-appointment term revised to 3 years (Oct 2026 - Oct 2029).
  • Shareholders approved the corrected tenure at the AGM.
  • No other changes to the original disclosure.